{"id":"bicarbonate-de-sodium","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypernatremia"},{"rate":null,"effect":"Hypokalemia"},{"rate":null,"effect":"Metabolic alkalosis"},{"rate":null,"effect":"Fluid overload"},{"rate":null,"effect":"Phlebitis (IV administration)"}]},"_chembl":null,"_dailymed":{"setId":"fc469943-9749-45ee-93f7-90fdbcdc7215","title":"DE LA CRUZ SODIUM BICARBONATE ANTACID (SODIUM BICARBONATE) POWDER [DLC LABORATORIES, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sodium bicarbonate is a weak base that dissociates in the bloodstream to provide bicarbonate ions, which buffer excess hydrogen ions and raise serum pH. It is used to treat metabolic acidosis by restoring the acid-base balance. Additionally, it can alkalinize urine, which enhances the renal excretion of certain drugs and toxins.","oneSentence":"Sodium bicarbonate acts as a systemic alkalizing agent that increases blood pH and bicarbonate levels to counteract acidosis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:23:55.609Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metabolic acidosis"},{"name":"Urinary alkalinization for drug/toxin elimination"},{"name":"Hyperkalemia management (adjunctive)"},{"name":"Severe lactic acidosis"}]},"trialDetails":[{"nctId":"NCT07403305","phase":"NA","title":"The Effect of Water Physical Exercise Program in Thermal Water and Hydropinotherapy on Cardiovascular Health","status":"NOT_YET_RECRUITING","sponsor":"Instituto Politécnico de Bragança","startDate":"2026-01-19","conditions":"Cardiovascular (CV) Risk","enrollment":80},{"nctId":"NCT06249061","phase":"NA","title":"Oral Sodium Bicarbonate for the Prevention of Labour Dystocia","status":"NOT_YET_RECRUITING","sponsor":"Liz Darling","startDate":"2025-12","conditions":"Labour Dystocia","enrollment":200},{"nctId":"NCT00001337","phase":"PHASE2","title":"Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1993-05-08","conditions":"Diffuse Large B-Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma","enrollment":348},{"nctId":"NCT06983509","phase":"","title":"Registry of Pre-mixed Solutions in Critically Ill Patients on the Continuous Renal Replacement Therapy","status":"RECRUITING","sponsor":"Vantive Health LLC","startDate":"2024-09-23","conditions":"Renal Insufficiency","enrollment":220},{"nctId":"NCT06942312","phase":"","title":"Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Helsinki University Central Hospital","startDate":"2025-05-01","conditions":"Non-alcoholic Fatty Liver Disease (NAFLD)","enrollment":30},{"nctId":"NCT06551779","phase":"NA","title":"Efficacy of Perineural Injection With Dextrose Versus Therapy Conventional Physics in Patients With Bell's Palsy","status":"COMPLETED","sponsor":"Celia Itxelt Infante Castro","startDate":"2024-02-09","conditions":"Bell´s Palsy","enrollment":21},{"nctId":"NCT01426295","phase":"PHASE2","title":"Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2011-04","conditions":"Hematologic Disease","enrollment":92},{"nctId":"NCT00720967","phase":"PHASE3","title":"Preop Hemodialysis or Intraop Ultrafiltration for Patients With Severe Renal Dysfunction Undergoing Open Heart Surgery","status":"UNKNOWN","sponsor":"University Hospital, Geneva","startDate":"2008-11","conditions":"Non-Dialysis Dependent Severe Renal Dysfunction, Cardiovascular Disease","enrollment":450}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Bicarbonate de sodium","genericName":"Bicarbonate de sodium","companyName":"Nantes University Hospital","companyId":"nantes-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sodium bicarbonate acts as a systemic alkalizing agent that increases blood pH and bicarbonate levels to counteract acidosis. Used for Metabolic acidosis, Urinary alkalinization for drug/toxin elimination, Hyperkalemia management (adjunctive).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}